T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FIRY
2626
Firy Inc
FIRY
$158M
| $274K | ﹤0.01% |
34,215
| – | – |
|
2627
SmartFinancial
SMBK
$899M
| $274K | ﹤0.01% |
7,667
+259
| +3% | +$9.27K |
|
2628
Savers
SVV
$1.67B
| $273K | ﹤0.01% |
20,581
+9,230
| +81% | +$106K |
|
2629
Alerus Financial
ALRS
$844M
| $272K | ﹤0.01% |
12,276
+1,560
| +15% | +$34.6K |
|
|
MAZE
2630
Maze Therapeutics
MAZE
$1.54B
| $272K | ﹤0.01% |
+10,474
| New | +$177K |
|
2631
AdvanSix
ASIX
$446M
| $271K | ﹤0.01% |
13,952
+839
| +6% | +$17.6K |
|
2632
Mission Produce
AVO
$1.15B
| $271K | ﹤0.01% |
22,489
-1,629
| -7% | -$20.1K |
|
2633
Vitamin Cottage Natural Grocers
NGVC
$646M
| $271K | ﹤0.01% |
6,766
+379
| +6% | +$14.6K |
|
2634
Zevra Therapeutics
ZVRA
$664M
| $271K | ﹤0.01% |
28,492
+2,802
| +11% | +$28.1K |
|
|
ELVR
2635
Elevra Lithium Ltd
ELVR
$1.23B
| $271K | ﹤0.01% |
+11,251
| New | +$234K |
|
2636
Southern Missouri Bancorp
SMBC
$850M
| $270K | ﹤0.01% |
5,124
+330
| +7% | +$18.4K |
|
2637
Vir Biotechnology
VIR
$1.52B
| $270K | ﹤0.01% |
47,136
+4,201
| +10% | +$21.5K |
|
2638
Navigator Holdings
NVGS
$1.27B
| $269K | ﹤0.01% |
17,325
+966
| +6% | +$15.4K |
|
2639
Red Robin
RRGB
$183M
| $269K | ﹤0.01% |
39,087
+7,500
| +24% | +$47.9K |
|
|
AEBI
2640
Aebi Schmidt Holding AG
AEBI
$1.06B
| $269K | ﹤0.01% |
+21,552
| New | +$271K |
|
2641
Aclaris Therapeutics
ACRS
$863M
| $267K | ﹤0.01% |
140,167
-26,200
| -16% | -$45.7K |
|
2642
Backblaze
BLZE
$1.26B
| $267K | ﹤0.01% |
28,696
+1,963
| +7% | +$14.4K |
|
2643
Five Star Bancorp
FSBC
$1.16B
| $267K | ﹤0.01% |
8,285
+662
| +9% | +$20.8K |
|
2644
Gossamer Bio
GOSS
$83.3M
| $265K | ﹤0.01% |
100,658
+5,367
| +6% | +$11.8K |
|
2645
Stereotaxis
STXS
$137M
| $265K | ﹤0.01% |
84,986
| – | – |
|
2646
Varex Imaging
VREX
$780M
| $265K | ﹤0.01% |
21,322
+361
| +2% | +$3.58K |
|
2647
ArriVent BioPharma
AVBP
$1.4B
| $265K | ﹤0.01% |
14,355
+2,902
| +25% | +$57K |
|
2648
Grindr
GRND
$2.74B
| $264K | ﹤0.01% |
17,530
+850
| +5% | +$14.9K |
|
2649
Rigel Pharmaceuticals
RIGL
$762M
| $264K | ﹤0.01% |
+9,285
| New | +$278K |
|
2650
Rush Enterprises Class B
RUSHB
$9.37B
| $264K | ﹤0.01% |
4,587
-108
| -2% | -$6.08K |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.